EA200970325A1 - [2-(6-фтор-1н-индол-3-илсульфанил)бензил]триметиламин для лечения аффективных расстройств - Google Patents

[2-(6-фтор-1н-индол-3-илсульфанил)бензил]триметиламин для лечения аффективных расстройств

Info

Publication number
EA200970325A1
EA200970325A1 EA200970325A EA200970325A EA200970325A1 EA 200970325 A1 EA200970325 A1 EA 200970325A1 EA 200970325 A EA200970325 A EA 200970325A EA 200970325 A EA200970325 A EA 200970325A EA 200970325 A1 EA200970325 A1 EA 200970325A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indol
treatment
ilsulfanil
trimetylamine
benzil
Prior art date
Application number
EA200970325A
Other languages
English (en)
Russian (ru)
Inventor
Ян Келер
Карстен Юль
Нейл Андерсон
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2007/000419 external-priority patent/WO2008037258A1/en
Publication of EA200970325A1 publication Critical patent/EA200970325A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
EA200970325A 2006-09-28 2007-09-27 [2-(6-фтор-1н-индол-3-илсульфанил)бензил]триметиламин для лечения аффективных расстройств EA200970325A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601251 2006-09-28
DKPA200700432 2007-03-20
PCT/DK2007/000419 WO2008037258A1 (en) 2006-09-28 2007-09-27 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

Publications (1)

Publication Number Publication Date
EA200970325A1 true EA200970325A1 (ru) 2009-12-30

Family

ID=40225153

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970325A EA200970325A1 (ru) 2006-09-28 2007-09-27 [2-(6-фтор-1н-индол-3-илсульфанил)бензил]триметиламин для лечения аффективных расстройств

Country Status (8)

Country Link
KR (1) KR20090074749A (no)
AR (1) AR062981A1 (no)
BR (1) BRPI0717038A2 (no)
CL (1) CL2007002789A1 (no)
EA (1) EA200970325A1 (no)
IL (1) IL197720A0 (no)
NO (1) NO20091642L (no)
TW (1) TW200829550A (no)

Also Published As

Publication number Publication date
BRPI0717038A2 (pt) 2013-10-01
AR062981A1 (es) 2008-12-17
TW200829550A (en) 2008-07-16
IL197720A0 (en) 2009-12-24
NO20091642L (no) 2009-04-27
KR20090074749A (ko) 2009-07-07
CL2007002789A1 (es) 2008-04-18

Similar Documents

Publication Publication Date Title
EA200801826A1 (ru) Дейтерированные производные катехоламина и лекарственные средства, содержащие указанные соединения
MX2010009268A (es) Compuestos que son inhibidores de erk.
EA200800147A1 (ru) Способ получения олмесартан медоксомила
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
BRPI0517438A (pt) composto, método para tratar a condição associada com atividade de receptor muscarìnico m4, uso do composto, e, composição farmacêutica
MX352516B (es) Compuestos terapeuticos.
SE0401342D0 (sv) Therapeutic compounds
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
NZ577392A (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
MX2010003989A (es) Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
EA200602180A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
RU2007122391A (ru) S-миртазапин для лечения приливов
RU2007121516A (ru) Лечение мастита с помощью энрофлоксацина
CL2010001471A1 (es) Un compuestos 2-fluoro-11-(piperazin-1.il) dibenzo´1,4 tiazepina, inhibidores net y antagonista moderado d2; procedimiento de preparacion del mismo; composicion farmaceutica; y uso en el tratamiento de trastornos psiquiatricos, entre otras enfermedades..
DE602005024836D1 (de) Verbindungen zur behandlung von dyslipidämie und anderer lipidstörungen
CY1112718T1 (el) Ν- (2-υδροξυαιθυλ) -ν-μεθυλ-4- (κινολιν-8-υλ (1- (θειαζολ-4-υλμεθυλ) πιπεριδιν- 4 -υλιδενο) μεθυλ) βενζαμιδιο, η μεθοδος παρασκευης του καθως και η χρηση του για τη θεραπευτικη αγωγη πονου, αγχους και καταθλιψης
EA200702201A1 (ru) Рофлумиласт для лечения лёгочной гипертензии
MX2009003299A (es) [2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina para el tratamiento de trastornos afectivos.
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
EA200970325A1 (ru) [2-(6-фтор-1н-индол-3-илсульфанил)бензил]триметиламин для лечения аффективных расстройств
RS51676B (en) USE OF AGOMELATIN FOR OBTAINING MEDICINES FOR SMITH-MAGENIS SYNDROME TREATMENT
UY29470A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos bipolares